Lausanne, Switzerland - March 11, 2021 - Saphetor SA, a Swiss-based precision medicine company specializing in analysis and interpretation of genomic data, announced today a distribution agreement with BioCat GmbH, a leading provider of innovative...

Lausanne, Switzerland - February 25, 2021 - Saphetor SA, a Switzerland-based precision medicine company using bioinformatics to apply human genome data to benefit people, announced today a distribution agreement with Annar Health Technologies...

Lausanne, Switzerland - July 22, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with ELTA 90...

Lausanne, Switzerland - July 10, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Decode...

Lausanne, Switzerland - May 19, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with TATAA...

Lausanne, Switzerland - May 18, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Thunder...

Lausanne, May 6, 2020. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions for clinical applications, announced today a partnership with Paragon Genomics, a California-based company...

Lausanne, Switzerland - April 9, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Whitehead...

Lausanne, Switzerland – April 1st, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Bio-Gene...

Lausanne, Switzerland - March 26, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Pharmigene, a...

Lausanne, Switzerland – March 26, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with ILC –...